Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | AFRM | V |
|---|---|---|
| Price | $69.18 | $358.60 |
| Change today | ▼ 0.08% | ▼ 0.20% |
| Market cap | $23.34B | $670.71B |
| Return, 3 months | -17.5% | +2.3% |
| Return, year to date | -7.1% | +2.9% |
| Return, 1 year | -7.0% | +3.9% |
| P/E (TTM) | 12.5 | 30.5 |
| P/B | 4.3 | 19.1 |
| P/E percentile vs own 5y | 79th | 49th |
| Dividend yield | – | 0.73% |
| Revenue growth (YoY, latest qtr) | +33.0% | +14.4% |
| Net profit growth (YoY) | +2,234.7% | +6.8% |
| Gross margin | 68.1% | 80.2% |
| Operating margin | 20.4% | 65.6% |
| Net margin | 45.3% | 50.3% |
| Return on equity | 45.1% | 61.8% |
| Analyst target vs. price | +46.8% | +19.6% |
| Analyst buy share | 83% | 96% |
| RSI (14) | 45 | 39 |
| 30-day volatility | 52.7% | 18.0% |
| Max drawdown, 1 year | -53.9% | -17.2% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
